RetractedArticleCancer prevention research (Philadelphia, Pa.)2012

Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.

Kotha Subbaramaiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.